Clinical trial · Observational
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| COVID-19 Infection | — | UNRESOLVED | — |
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational (survey administration)
- description
- Patients complete a survey over 10 minutes.
- interventionNames
- Other: Survey Administration
Primary outcomes (8)
- measure
- Experiences during the COVID-19 pandemic
- timeFrame
- Survey completion Up to 2 months
- description
- Including exposure, risk factors, testing, isolation, seropositivity, hospitalization, or loss of family or friends.
- measure
- COVID-19-specific psychological distress
- timeFrame
- Survey completion Up to 2 months
- measure
- COVID-19-specific health
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients who have signed consent for PA15-0336 * Has an active email address and can be contacted via MyChart * Documentation of being alive per the cancer registry
References
Publications (0)
Data not yet available